• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MINERVA SURGICAL, INC. GENESYS HTA ENDOMETRIAL ABLATION SYSTEM; ENDOMTRIAL ABLATION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MINERVA SURGICAL, INC. GENESYS HTA ENDOMETRIAL ABLATION SYSTEM; ENDOMTRIAL ABLATION DEVICE Back to Search Results
Model Number M006580210
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Partial thickness (Second Degree) Burn (2694)
Date of Event 01/30/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Manufacturer contacted the physician to obtain additional information related to this event.The physician stated that the system did not malfunction as it alerted her of the fluid loss as designed.It was confirmed the patient sustained a 2nd degree burn to the vagina.The physician reported the patient was hospitalized for pain management for less than 48 hours.Per agreement between fda and manufacturer, effective october 27th, 2008, a 2nd degree burn, not classified as "extensive" and does not involve both internal and external anatomy, shall be reported to fda as a malfunction event type.Based on the information reviewed, there is no indication of a product deficiency.All handpieces meet all qa specifications prior to being released, including adequate sterilization.The ifu instructs the user to "during ablation, the saline temperature continues to rise until 90°c is reached, and the user must continuously: monitor the cervical seal for fluid loss and to confirm a tight cervical seal.Maintain a stable procedure sheath position throughout the procedure.Monitor the screen for fluid loss level." warnings and cautions related to an event of this nature are included in the ifu for genesys hta, including but not limited to: "the physician must maintain control of the procedure sheath (i.E., not hand off to another individual) for the duration of the treatment to avoid compromising the cervical seal.A compromise of the cervical seal could result in fluid leakage through the cervix, which could result in thermal injury to surrounding tissue"."do not place the procedure sheath tubing over the patient's leg or in contact with any part of the user's or patient's anatomy, as the tubing carries hot fluid and contact could result in thermal injury.The temperature of the tubing could be up to 55°c." "throughout the procedure, carefully observe the junction of the procedure sheath with the external cervical os to confirm a tight cervical seal and that there is no fluid leakage".
 
Event or Problem Description
It was reported the system alerted the physician of fluid loss three times throughout the treatment cycle.The physician did not notice a cervical leak of fluid until the third alert when the treatment cycle was aborted.Physician observed fluid on the cervix and the posterior of the vaginal wall.Once completed, a small vaginal burn was noted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GENESYS HTA ENDOMETRIAL ABLATION SYSTEM
Common Device Name
ENDOMTRIAL ABLATION DEVICE
Manufacturer (Section D)
MINERVA SURGICAL, INC.
4255 burton drive
santa clara CA 95054
Manufacturer (Section G)
MINERVA SURGICAL, INC.
4255 burton drive
santa clara CA 95054
Manufacturer Contact
michelle becker
4255 burton drive
santa clara, CA 95054
MDR Report Key16452509
Report Number3011011193-2023-00003
Device Sequence Number5859989
Product Code MNB
UDI-Device Identifier08714729809456
UDI-Public08714729809456
Combination Product (Y/N)N
Initial Reporter StateGA
Initial Reporter CountryUS
PMA/510(K) Number
P000040
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 02/28/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date02/16/2024
Device Model NumberM006580210
Device Catalogue NumberM006580210
Device Lot Number28956305
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/30/2023
Initial Report FDA Received Date02/28/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other; Hospitalization;
Patient SexFemale
-
-